11 March 2021 1 Min Read
Roche says adding Actemra to remdesivir does not reduce Covid-19 hospitalisation
The trial combining the rheumatoid arthritis drug with the anti-viral had disappointing results with regard to Covid-19 pneumonia
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe Sign In